Alizapride
- Level
- Commodity
- Parent
- 51171800
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171827This classification denotes an antiemetic agent with the molecular formula C16H21N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P55703ZRZY, chemically known as 1h-benzotriazole-5-carboxamide, 6-methoxy-n-((1-(2-propenyl)-2-pyrrolidinyl)methyl)- but generally known as alizapride, which bears US NIH Compound Identifier 43008. Alizapride most often comes in base and hydrochloride forms. European Medicines Agency schedules Alizapride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05332MIG. The term ALIZAPRIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). World Health Organization schedules alizapride in its Anatomical Therapeutic Chemical (ATC) Classification. ALIZAPRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alizapride under HS 29339990 and SITC 51577. As of Q4 2014, ALIZAPRIDE remains the US FDA Preferred Term for this commodity. Alizapride bears US NLM identifiers UMLS ID C0051162 and NCI Concept Code C995. SMILES: O=C(NCC1N(CCC1)CC=C)C1C(OC)CC2N[NH]NC2C1.
Same parent
Under 51171800 · 49Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.